1-5 of 5
infrainguinal bypass
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II Study

Solomon A. Graf, MD, Ryan D. Cassaday, MD, Karolyn K. Morris, BA, Sanaz Behnia, MD, Qian Vicky Wu, PhD, Jenna M. Voutsinas, MPH, Ryan C. Lynch, MD, Elizabeth Krakow, MD, Heather A. Rasmussen, BS, Thomas R. Chauncey, MD PhD, Sandra Kanan, MSN, ARNP, Lorinda A. Soma, MD, Stephen D. Smith, MD, Ajay K. Gopal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1596.
https://doi.org/10.1182/blood-2019-126086
Published: 2019
Journal Articles

The Prognostic Value of IgH Clonality in Bone Marrow with Negative Pathology in B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Ayato Tsukamoto, MD PhD, Sho Yamazaki, MD PhD, Fumihiko Nakamura, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5298.
https://doi.org/10.1182/blood-2018-99-114628
Published: 2018
Journal Articles

Ixazomib in Previously Untreated Indolent B-Cell Non-Hodgkin Lymphoma

Solomon A. Graf, MD, Ryan C. Lynch, MD, David G. Coffey, MD, Mazyar Shadman, MD MPH, Sandra Kanan, MSN, ARNP, Edward N. Libby, III, MD, Edus H. Warren, MD PhD, Colin Godwin, Ted Gooley, PhD, Jonathan R. Fromm, MD PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5326.
https://doi.org/10.1182/blood-2018-99-117572
Published: 2018
Journal Articles

Ibrutinib Is Effective in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Results from a Prospective Phase II Study

Solomon A. Graf, MD, Ryan D. Cassaday, MD, Karolyn K. Morris, Heather A. Rasmussen, BS, Pamela S. Becker, MD, Thomas R. Chauncey, MD PhD, Sandra Kanan, MSN, ARNP, Lorinda A. Soma, MD, Stephen D. Smith, MD, Ajay K. Gopal, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2954.
https://doi.org/10.1182/blood-2018-99-115476
Published: 2018
Journal Articles

Heparin-PF4 Antibodies Are Frequent after Vascular Surgery, but Not a Frequent Cause of Graft Thrombosis or Thrombocytopenia.

Tamas Alexy, MD, PhD, Sony Tucker, MD, Soames Boyle, Leanne Rochanda, Douglas Hood, MD, Vincent L. Rowe, MD, Fred A. Weaver, MD, Howard A. Liebman, MD
Journal: Blood
Blood (2006) 108 (11): 1491.
https://doi.org/10.1182/blood.V108.11.1491.1491
Published: 2006